|
1
|
Fibrotic disorders in the eye: targets of gene therapy.
|
Prog Retin Eye Res
|
2008
|
1.40
|
|
2
|
TGF beta in fibroproliferative diseases in the eye.
|
Front Biosci (Schol Ed)
|
2009
|
1.16
|
|
3
|
Effect of overexpression of PPARgamma on the healing process of corneal alkali burn in mice.
|
Am J Physiol Cell Physiol
|
2007
|
1.16
|
|
4
|
Loss of tumor necrosis factor alpha potentiates transforming growth factor beta-mediated pathogenic tissue response during wound healing.
|
Am J Pathol
|
2006
|
1.14
|
|
5
|
Effect of Smad7 gene overexpression on transforming growth factor beta-induced retinal pigment fibrosis in a proliferative vitreoretinopathy mouse model.
|
Arch Ophthalmol
|
2007
|
1.03
|
|
6
|
Epithelial-mesenchymal transition as a therapeutic target for prevention of ocular tissue fibrosis.
|
Endocr Metab Immune Disord Drug Targets
|
2008
|
1.02
|
|
7
|
Transforming growth factor beta signal transduction: a potential target for maintenance/restoration of transparency of the cornea.
|
Eye Contact Lens
|
2010
|
1.02
|
|
8
|
Impaired cutaneous wound healing with excess granulation tissue formation in TNFalpha-null mice.
|
Arch Dermatol Res
|
2009
|
1.01
|
|
9
|
TRPV1 involvement in inflammatory tissue fibrosis in mice.
|
Am J Pathol
|
2011
|
1.01
|
|
10
|
Inhibitory effect of blocking TGF-beta/Smad signal on injury-induced fibrosis of corneal endothelium.
|
Mol Vis
|
2008
|
0.99
|
|
11
|
Corneal wound healing in an osteopontin-deficient mouse.
|
Invest Ophthalmol Vis Sci
|
2008
|
0.95
|
|
12
|
Neurotrophic keratopathy; its pathophysiology and treatment.
|
Histol Histopathol
|
2010
|
0.93
|
|
13
|
Loss of osteopontin perturbs the epithelial-mesenchymal transition in an injured mouse lens epithelium.
|
Lab Invest
|
2007
|
0.91
|
|
14
|
Connective tissue growth factor modulates extracellular matrix production in human subconjunctival fibroblasts and their proliferation and migration in vitro.
|
Jpn J Ophthalmol
|
2008
|
0.86
|
|
15
|
Suppression of injury-induced conjunctiva scarring by peroxisome proliferator-activated receptor gamma gene transfer in mice.
|
Invest Ophthalmol Vis Sci
|
2008
|
0.85
|
|
16
|
Impaired angiogenic response in the corneas of mice lacking osteopontin.
|
Invest Ophthalmol Vis Sci
|
2009
|
0.84
|
|
17
|
JNK MAPK signaling contributes in vivo to injury-induced corneal epithelial migration.
|
Ophthalmic Res
|
2009
|
0.84
|
|
18
|
Impaired cornea wound healing in a tenascin C-deficient mouse model.
|
Lab Invest
|
2012
|
0.83
|
|
19
|
Suppression of injury-induced epithelial-mesenchymal transition in a mouse lens epithelium lacking tenascin-C.
|
Mol Vis
|
2010
|
0.83
|
|
20
|
Impaired angiogenic response in the cornea of mice lacking tenascin C.
|
Invest Ophthalmol Vis Sci
|
2011
|
0.82
|
|
21
|
TNFalpha suppression of corneal epithelium migration.
|
Mol Vis
|
2007
|
0.79
|
|
22
|
Wakayama symposium: modulation of wound healing response in the corneal stroma by osteopontin and tenascin-C.
|
Ocul Surf
|
2012
|
0.76
|